Development of the Oncotype DX®
Breast Recurrence Score™
The Oncotype DX Breast Recurrence Score was developed using a rigorous four-step process.
THE BREAST RECURRENCE SCORE INCORPORATES A UNIQUE SET OF GENES THAT PROVIDE BOTH PROGNOSTIC AND PREDICTIVE INFORMATION, SETTING IT APART FROM ANY OTHER GENOMIC TEST FOR EARLY-STAGE INVASIVE BREAST CANCER
Next: Extensive Validation